690
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Relationship Between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Escherichia coli Isolates from Ningbo, China

, , , , , , & show all
Pages 2865-2878 | Published online: 03 Jun 2022

References

  • Tadesse DA, Zhao S, Tong E, et al. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. Emerg Infect Dis. 2012;18(5):741‒749. doi:10.3201/eid1805.111153
  • Kahn LH. Antimicrobial resistance: a one health perspective. Trans R Soc Trop Med Hyg. 2017;111(6):255–260. doi:10.1093/trstmh/trx050
  • Qiao M, Ying GG, Singer AC, et al. Review of antibiotic resistance in China and its environment. Environ Int. 2018;110:160–172. doi:10.1016/j.envint.2017.10.016
  • Pokharel S, Shrestha P, Adhikari B. Antimicrobial use in food animals and human health: time to implement ‘one health’ approach. Antimicrob Resist Infect Control. 2020;9(1):181. doi:10.1186/s13756-020-00847-x
  • Shin B, Park W. Zoonotic diseases and phytochemical medicines for microbial infections in veterinary science: current state and future perspective. Front Vet Sci. 2018;5:166. doi:10.3389/fvets.2018.00166
  • Jang J, Hur HG, Sadowsky MJ, et al. Environmental Escherichia coli: ecology and public health implications-a review. J Appl Microbiol. 2017;123(3):570–581. doi:10.1111/jam.13468
  • Denamur E, Clermont O, Bonacorsi S, et al. The population genetics of pathogenic Escherichia coli. Nat Rev Microbiol. 2021;19(1):37–54. doi:10.1038/s41579-020-0416-x
  • Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. doi:10.1038/nrmicro3432
  • Alvarez-Fraga L, Phan MD, Goh KGK, et al. Differential Afa/Dr fimbriae expression in the multidrug-resistant Escherichia coli ST131 clone. mBio. 2022;13:e0351921. doi:10.1128/mbio.03519-21
  • Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347(4):240–247. doi:10.1056/NEJMoa012657
  • Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012;88(Suppl):S69–S74. doi:10.1016/S0378-3782(12)70019-1
  • Ecker KL, Donohue PK, kim KS, et al. The impact of group B streptococcus prophylaxis on late-onset neonatal infections. J Perinatol. 2013;33(3):206–211. doi:10.1038/jp.2012.76
  • Bergin SP, Thaden JT, Ericson JE, et al. Neonatal Escherichia coli bloodstream infections: clinical outcomes and impact of initial antibiotic therapy. Pediatr Infect Dis J. 2015;34(9):933–936. doi:10.1097/INF.0000000000000769
  • Bauserman MS, Laughon MM, Hornik CP, et al. Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis. Pediatr Infect Dis J. 2013;32(3):208–212. doi:10.1097/INF.0b013e318275058a
  • Eybpoosh S, Mostaan S, Gouya MM, et al. Frequency of five Escherichia Coli pathotypes in Iranian adults and children with acute diarrhea. PLoS One. 2021;16(2):e0245470. doi:10.1371/journal.pone.0245470
  • Ko H, Maymani H, Rojas-Hernandez C. Hemolytic uremic syndrome associated with Escherichia coli O157: h7 infection in older adults: a case report and review of the literature. J Med Case Rep. 2016;10(175). doi:10.1186/s13256-016-0970-z
  • Moradigaravand D, Palm M, Farewell A, et al. Prediction of antibiotic resistance in Escherichia coli from large-scale pan-genome data. PLoS Comput Biol. 2018;14(12):e1006258. doi:10.1371/journal.pcbi.1006258
  • Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66(1):1–14. doi:10.1093/jac/dkq415
  • Petty NK, Ben Zakour NL, Stanton-Cook M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA. 2014;111(15):5694–5699. doi:10.1073/pnas.1322678111
  • Roer L, Hansen F, Stegger M, et al. Novel mcr-3 variant, encoding mobile colistin resistance, in an ST131 Escherichia coli isolate from bloodstream infection, Denmark, 2014. Euro Surveill. 2017;22(31). doi:10.2807/1560-7917.ES.2017.22.31.30584
  • Behzadi P, Garcia-Perdomo HA, Karpinski TM, et al. Metallo-β-lactamases: a review. Mol Biol Rep. 2020;47(8):6281–6294. doi:10.1007/s11033-020-05651-9
  • Issakhanian L, Behzadi P. Antimicrobial agents and urinary tract infections. Curr Pharm Des. 2019;25(12):1409–1423. doi:10.2174/1381612825999190619130216
  • Alizade H, Fallah F, Ghanbarpour R, et al. Phylogenetic groups, extended-spectrum β-lactamases and metallo-β-lactamase in Escherichia coli isolated from fecal samples of patients with diarrhea in Iran. Gastroenterol Hepatol Bed Bench. 2015;8(3):207–214.
  • Poirel L, Lagrutta E, Taylor P, et al. Emergence of Metallo-β-Lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010;54(11):4914–4916. doi:10.1128/AAC.00878-10
  • Nepal K, Pant ND, Neupane B, et al. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal. Ann Clin Microbiol Antimicrob. 2017;16(1):62. doi:10.1186/s12941-017-0236-7
  • Wiedemann B, Heisig A, Heisig P. Uncomplicated urinary tract infections and antibiotic resistance-epidemiological and mechanistic aspects. Antibiotics. 2014;3(3):341–352. doi:10.3390/antibiotics3030341
  • Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol. 2010;59(3):227–238. doi:10.1111/j.1574-695X.2010.00665.x
  • Singhai M, Malik A, Shahid M, et al. A study on device-related infections with special reference to biofilm production and antibiotic resistance. J Glob Infect Dis. 2012;4(4):193–198. doi:10.4103/0974-777X.103896
  • Flemming HC, Wingender J, Szewzyk U, et al. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016;14(9):563–575. doi:10.1038/nrmicro.2016.94
  • McDougald D, Rice SA, Barraud N, et al. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol. 2011;10(1):39–50. doi:10.1038/nrmicro2695
  • Delcaru C, Alexandru I, Podgoreanu P, et al. Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens. 2016;5(4):65. doi:10.3390/pathogens5040065
  • Behzadi P, Urban E, Gajdacs M. Association between biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study. Diseases. 2020;8(2):17. doi:10.3390/diseases8020017
  • Omar A, Wright JB, Schultz G, et al. Microbial biofilms and chronic wounds. Microorganisms. 2017;5(1):9. doi:10.3390/microorganisms5010009
  • Vestby LK, Gronseth T, Simm R, et al. Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics. 2020;9(2):59. doi:10.3390/antibiotics9020059
  • Huang Z, Pan H, Zhang P, et al. Prevalence and antimicrobial resistance patterns of diarrheagenic Escherichia coli in shanghai, China. Pediatr Infect Dis J. 2016;35(8):835–839. doi:10.1097/INF.0000000000001190
  • Tapiainen T, Hanni AM, Salo J, et al. Escherichia coli biofilm formation and recurrences of urinary tract infections in children. Eur J Clin Microbiol Infect Dis. 2014;33(1):111–115. doi:10.1007/s10096-013-1935-4
  • Qi L, Li H, Zhang C, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol. 2016;7(483). doi:10.3389/fmicb.2016.00483
  • Abidi SH, Sherwani SK, Siddiqui TR, et al. Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol. 2013;13:57. doi:10.1186/1471-2415-13-57
  • Khot PD, Fisher MA. Novel approach for differentiating shigella species and Escherichia coli by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2013;51(11):3711–3716. doi:10.1128/JCM.01526-13
  • Stepanovic S, Vukovic D, Hola V, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007;115(8):891–899. doi:10.1111/j.1600-0463.2007.apm_630.x
  • Qian W, Yang M, Li X, et al. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro. Colloids Surf B Biointerfaces. 2020;191:111003. doi:10.1016/j.colsurfb.2020.111003
  • Alizade H. Escherichia coli in Iran: an overview of antibiotic resistance: a review article. Iran J Public Health. 2018;47(1):1–12.
  • Ahmed N. Antibiotic resistance profile in relation to virulence genes fimH, hlyA and usp of uropathogenic E. coli isolates in Lahore, Pakistan. Trop Biomed. 2020;36(2):559–568.
  • Salehzadeh A, Zamani H. Characterization of (Uropathogenic) E. coli isolated from urinary tract infections: phylogenetic typing and distribution of virulence-associated traits. Br J Biomed Sci. 2018;75(1):40–42. doi:10.1080/09674845.2017.1336834
  • Allami M, BahreiniM, Sharifmoghadam MR. Antibiotic resistance, phylogenetic typing, and virulence genes profile analysis of uropathogenic Escherichia coli isolated from patients in southern Iraq. J Appl Genet. 2022; 63(2):401–412. doi:10.1007/s13353-022-00683-2
  • Ho PL, Chu YPS, Lo WU, et al. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients. J Med Microbiol. 2015;64:243–247. doi:10.1111/j.1469-0691.2009.02941.x
  • Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American urinary tract infection collaborative alliance (nautica). Int J Antimicrob Agents. 2006;27(6):468–475. doi:10.1016/j.ijantimicag.2006.02.009
  • Huttner A, Verhaegh EM, Harbarth S, et al. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015;70(9):2456–2464. doi:10.1093/jac/dkv147
  • He P, Sun Q, Shi L, et al. Rational use of antibiotics in the context of China’s health system reform. BMJ. 2019;365:l4016. doi:10.1136/bmj.l4016
  • Sadeghi M, Ebrahim-Saraie HS, Mojtahedi A. Prevalence of ESBL and AmpC genes in E. coli isolates from urinary tract infections in the north of Iran. New Microbes and New Infections. 2021;45:100947. doi:10.1016/j.nmni.2021.100947
  • Sid Ahmed MA, Bansal D, Acharya A, et al. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control. 2016;5(4). doi:10.1186/s13756-016-0103-x
  • Momtaz H, Rahimi E, Moshkelani S. Molecular detection of antimicrobial resistance genes in E. coli isolated from slaughtered commercial chickens in Iran. Vet Med-Czech. 2012;57(4):193–197. doi:10.17221/5916-Vetmed
  • Nawaz Z, Zahoor MK, Siddique AB, et al. Molecular identification of blactx-m and blatem genes among multi-drug resistant enteropathogenic Escherichia coli isolated from children. Pak J Pharm Sci. 2019;32(3):1215–1218.
  • Dumaru R, Baral R, Shrestha LB. Study of biofilm formation and antibiotic resistance pattern of gram-negative Bacilli among the clinical isolates at BPKIHS, Dharan. BMC Res Notes. 2019;12(1):38. doi:10.1186/s13104-019-4084-8
  • Avila-Novoa MG, Solis-Velazquez OA, Rangel-Lopez DE, et al. Biofilm formation and detection of fluoroquinolone- and carbapenem-resistant genes in multidrug-resistant Acinetobacter baumannii. Can J Infect Dis Med Microbiol. 2019;2019:3454907. doi:10.1155/2019/3454907
  • Katongole P, Nalubega F, Florence NC, et al. Biofilm formation, antimicrobial susceptibility and virulence genes of uropathogenic Escherichia coli isolated from clinical isolates in Uganda. BMC Infect Dis. 2020;20(1):453. doi:10.1186/s12879-020-05186-1
  • Tajbakhsh E, Ahmadi P, Abedpour-Dehkordi E, et al. Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran. Antimicrob Resist Infect Control. 2016;5(11). doi:10.1186/s13756-016-0109-4
  • Sharma G, Sharma S, Sharma P, et al. Escherichia coli biofilm: development and therapeutic strategies. J Appl Microbiol. 2016;121(2):309–319. doi:10.1111/jam.13078
  • Cepas V, Lopez Y, Munoz E, et al. Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria. Microb Drug Resist. 2019;25(1):72–79. doi:10.1089/mdr.2018.0027
  • Mittal S, Sharma M, Chaudhary U. Biofilm and multidrug resistance in uropathogenic Escherichia coli. Pathog Glob Health. 2015;109(1):26–29. doi:10.1179/2047773215Y.0000000001
  • Perez LR. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J Chemother. 2015;27(1):13–16. doi:10.1179/1973947813Y.0000000159
  • Fabrega A, Soto SM, Balleste-Delpierre C, et al. Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica. J Antimicrob Chemother. 2014;69(7):1815–1824. doi:10.1093/jac/dku078
  • Mizan MFR, Jahid IK, Kim M, et al. Variability in biofilm formation correlates with hydrophobicity and quorum sensing among Vibrio parahaemolyticus isolates from food contact surfaces and the distribution of the genes involved in biofilm formation. Biofouling. 2016;32(4):497–509. doi:10.1080/08927014.2016.1149571
  • Ciofu O, Rojo-Molinero E, Macia MD, et al. Antibiotic treatment of biofilm infections. APMIS. 2017;125(4):304–319. doi:10.1111/apm.12673
  • Borowiak M, Fischer J, Hammerl JA, et al. Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting salmonella enterica subsp. Enterica serovar Paratyphi B. J Antimicrob Chemother. 2017;72(12):3317–3324. doi:10.1093/jac/dkx327
  • Literak I, Manga I, Wojczulanis-Jakubas K, et al. Enterobacter cloacae with a novel variant of act ampc beta-lactamase originating from glaucous gull (Larus hyperboreus) in Svalbard. Vet Microbiol. 2014;171(3–4):432–435. doi:10.1016/j.vetmic.2014.02.015
  • Zhao X, Yang J, Ju Z, et al. Molecular characterization of antimicrobial resistance in Escherichia coli from rabbit farms in Tai’an, China. Biomed Res Int. 2018;2018:8607647. doi:10.1155/2018/8607647
  • Mlynarcik P, Kolar M. Molecular mechanisms of polymyxin resistance and detection of mcr genes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163(1):28–38. doi:10.5507/bp.2018.070